Ron Prywes - Publications

Affiliations: 
Columbia University, New York, NY 

64/94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Low-Calle AM, Ghoneima H, Ortega N, Cuibus AM, Katz C, Prives C, Prywes R. A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and Cellular Biology. 1-16. PMID 38270135 DOI: 10.1080/10985549.2023.2292037  0.765
2023 Low-Calle AM, Ghoneima H, Ortega N, Cuibus AM, Katz C, Tong D, Prives C, Prywes R. A non-canonical Hippo pathway represses the expression of ΔNp63. Biorxiv : the Preprint Server For Biology. PMID 36824867 DOI: 10.1101/2023.02.13.528336  0.761
2017 Joy M, Gau D, Castellucci N, Prywes R, Roy P. The Myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms. The Journal of Biological Chemistry. PMID 28546428 DOI: 10.1074/Jbc.M117.781104  0.474
2016 Yoh KE, Regunath K, Guzman A, Lee SM, Pfister NT, Akanni O, Kaufman LJ, Prives C, Prywes R. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 27681615 DOI: 10.1073/Pnas.1613417113  0.464
2015 Kircher P, Hermanns C, Nossek M, Drexler MK, Grosse R, Fischer M, Sarikas A, Penkava J, Lewis T, Prywes R, Gudermann T, Muehlich S. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration. Science Signaling. 8: ra112. PMID 26554816 DOI: 10.1126/Scisignal.Aad2959  0.653
2015 Hayashi K, Murai T, Oikawa H, Masuda T, Kimura K, Muehlich S, Prywes R, Morita T. A novel inhibitory mechanism of MRTF-A/B on the ICAM-1 gene expression in vascular endothelial cells. Scientific Reports. 5: 10627. PMID 26024305 DOI: 10.1038/Srep10627  0.363
2015 Lee SM, Lee SB, Prywes R, Vulpe CD. Iron deficiency upregulates Egr1 expression. Genes & Nutrition. 10: 468. PMID 25981695 DOI: 10.1007/S12263-015-0468-0  0.373
2015 Yoh K, Prywes R. Pathway Regulation of p63, a Director of Epithelial Cell Fate. Frontiers in Endocrinology. 6: 51. PMID 25972840 DOI: 10.3389/Fendo.2015.00051  0.469
2013 Henckels E, Prywes R. Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells. F1000research. 2: 229. PMID 25339983 DOI: 10.12688/F1000Research.2-229.V1  0.628
2013 Lewis TC, Prywes R. Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochimica Et Biophysica Acta. 1829: 1147-59. PMID 23948603 DOI: 10.1016/J.Bbagrm.2013.08.002  0.66
2013 Hampl V, Martin C, Aigner A, Hoebel S, Singer S, Frank N, Sarikas A, Ebert O, Prywes R, Gudermann T, Muehlich S. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence. Embo Molecular Medicine. 5: 1367-82. PMID 23853104 DOI: 10.1002/Emmm.201202406  0.366
2012 Gade P, Ramachandran G, Maachani UB, Rizzo MA, Okada T, Prywes R, Cross AS, Mori K, Kalvakolanu DV. An IFN-γ-stimulated ATF6-C/EBP-β-signaling pathway critical for the expression of Death Associated Protein Kinase 1 and induction of autophagy. Proceedings of the National Academy of Sciences of the United States of America. 109: 10316-21. PMID 22699507 DOI: 10.1073/Pnas.1119273109  0.44
2012 Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS, Lynch KA, Okada T, Aronow BJ, Osinska H, Prywes R, Lorenz JN, Mori K, Lawler J, Robbins J, et al. A thrombospondin-dependent pathway for a protective ER stress response. Cell. 149: 1257-68. PMID 22682248 DOI: 10.1016/J.Cell.2012.03.050  0.359
2012 Muehlich S, Hampl V, Khalid S, Singer S, Frank N, Breuhahn K, Gudermann T, Prywes R. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1. Oncogene. 31: 3913-23. PMID 22139079 DOI: 10.1038/Onc.2011.560  0.421
2010 Lee SM, Vasishtha M, Prywes R. Activation and repression of cellular immediate early genes by serum response factor cofactors. The Journal of Biological Chemistry. 285: 22036-49. PMID 20466732 DOI: 10.1074/Jbc.M110.108878  0.481
2008 Muehlich S, Wang R, Lee SM, Lewis TC, Dai C, Prywes R. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Molecular and Cellular Biology. 28: 6302-13. PMID 18694962 DOI: 10.1128/Mcb.00427-08  0.625
2005 Shen J, Prywes R. ER stress signaling by regulated proteolysis of ATF6. Methods (San Diego, Calif.). 35: 382-9. PMID 15804611 DOI: 10.1016/J.Ymeth.2004.10.011  0.519
2005 Shen J, Snapp EL, Lippincott-Schwartz J, Prywes R. Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Molecular and Cellular Biology. 25: 921-32. PMID 15657421 DOI: 10.1128/Mcb.25.3.921-932.2005  0.534
2004 Cen B, Selvaraj A, Prywes R. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. Journal of Cellular Biochemistry. 93: 74-82. PMID 15352164 DOI: 10.1002/Jcb.20199  0.693
2004 Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. Bmc Molecular Biology. 5: 13. PMID 15329155 DOI: 10.1186/1471-2199-5-13  0.667
2004 Shen J, Prywes R. Dependence of site-2 protease cleavage of ATF6 on prior site-1 protease digestion is determined by the size of the luminal domain of ATF6. The Journal of Biological Chemistry. 279: 43046-51. PMID 15299016 DOI: 10.1074/Jbc.M408466200  0.497
2003 Selvaraj A, Prywes R. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. The Journal of Biological Chemistry. 278: 41977-87. PMID 14565952 DOI: 10.1074/Jbc.M305679200  0.676
2003 Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, Prywes R. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Molecular and Cellular Biology. 23: 6597-608. PMID 12944485 DOI: 10.1128/Mcb.23.18.6597-6608.2003  0.704
2002 Gupta P, Prywes R. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. The Journal of Biological Chemistry. 277: 50550-6. PMID 12414794 DOI: 10.1074/Jbc.M209799200  0.442
2002 Shen J, Chen X, Hendershot L, Prywes R. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Developmental Cell. 3: 99-111. PMID 12110171 DOI: 10.1016/S1534-5807(02)00203-4  0.54
2002 Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, Kaufman RJ. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes & Development. 16: 452-66. PMID 11850408 DOI: 10.1101/Gad.964702  0.497
2002 Chen X, Shen J, Prywes R. The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. The Journal of Biological Chemistry. 277: 13045-52. PMID 11821395 DOI: 10.1074/Jbc.M110636200  0.508
2000 Ye J, Rawson RB, Komuro R, Chen X, Davé UP, Prywes R, Brown MS, Goldstein JL. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Molecular Cell. 6: 1355-64. PMID 11163209 DOI: 10.1016/S1097-2765(00)00133-7  0.344
2000 Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, Prywes R. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. The Journal of Biological Chemistry. 275: 27013-20. PMID 10856300 DOI: 10.1074/Jbc.M003322200  0.483
2000 Wang Y, Prywes R. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene. 19: 1379-85. PMID 10723128 DOI: 10.1038/Sj.Onc.1203443  0.413
1999 Youn HD, Sun L, Prywes R, Liu JO. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science (New York, N.Y.). 286: 790-3. PMID 10531067 DOI: 10.1126/Science.286.5440.790  0.402
1999 Ornatsky OI, Cox DM, Tangirala P, Andreucci JJ, Quinn ZA, Wrana JL, Prywes R, Yu YT, McDermott JC. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Research. 27: 2646-54. PMID 10373581 DOI: 10.1093/Nar/27.13.2646  0.452
1999 Chen X, Prywes R. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Molecular and Cellular Biology. 19: 4695-702. PMID 10373518 DOI: 10.1128/Mcb.19.7.4695  0.457
1999 Soh JW, Lee EH, Prywes R, Weinstein IB. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Molecular and Cellular Biology. 19: 1313-24. PMID 9891065 DOI: 10.1128/Mcb.19.2.1313  0.435
1998 Wang Y, Falasca M, Schlessinger J, Malstrom S, Tsichlis P, Settleman J, Hu W, Lim B, Prywes R. Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 9: 513-22. PMID 9690619  0.536
1998 Thuerauf DJ, Arnold ND, Zechner D, Hanford DS, DeMartin KM, McDonough PM, Prywes R, Glembotski CC. p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6. The Journal of Biological Chemistry. 273: 20636-43. PMID 9685422 DOI: 10.1074/Jbc.273.32.20636  0.407
1998 Clarke N, Arenzana N, Hai T, Minden A, Prywes R. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Molecular and Cellular Biology. 18: 1065-73. PMID 9448004 DOI: 10.1128/Mcb.18.2.1065  0.646
1997 Zhu C, Johansen FE, Prywes R. Interaction of ATF6 and serum response factor. Molecular and Cellular Biology. 17: 4957-66. PMID 9271374 DOI: 10.1128/Mcb.17.9.4957  0.478
1997 Coso OA, Montaner S, Fromm C, Lacal JC, Prywes R, Teramoto H, Gutkind JS. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway. The Journal of Biological Chemistry. 272: 20691-7. PMID 9252389 DOI: 10.1074/jbc.272.33.20691  0.358
1996 Croissant JD, Kim JH, Eichele G, Goering L, Lough J, Prywes R, Schwartz RJ. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Developmental Biology. 177: 250-64. PMID 8660892 DOI: 10.1006/Dbio.1996.0160  0.443
1995 Joliot V, Demma M, Prywes R. Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factor. Nature. 373: 632-5. PMID 7854423 DOI: 10.1038/373632A0  0.356
1995 Han TH, Prywes R. Regulatory role of MEF2D in serum induction of the c-jun promoter. Molecular and Cellular Biology. 15: 2907-15. PMID 7760790 DOI: 10.1128/Mcb.15.6.2907  0.423
1995 Johansen FE, Prywes R. Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochimica Et Biophysica Acta. 1242: 1-10. PMID 7626651 DOI: 10.1016/0304-419X(94)00014-S  0.404
1994 Johansen FE, Prywes R. Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Molecular and Cellular Biology. 14: 5920-8. PMID 8065325 DOI: 10.1128/Mcb.14.9.5920  0.424
1993 Manak JR, Prywes R. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression. Oncogene. 8: 703-11. PMID 8437853  0.302
1993 Chen X, Farmer G, Zhu H, Prywes R, Prives C. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes & Development. 7: 1837-49. PMID 8405994 DOI: 10.1101/Gad.7.10.1837  0.391
1993 Johansen FE, Prywes R. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Molecular and Cellular Biology. 13: 4640-7. PMID 8336707 DOI: 10.1128/Mcb.13.8.4640  0.368
1992 Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. Wild-type p53 activates transcription in vitro. Nature. 358: 83-6. PMID 1614538 DOI: 10.1038/358083A0  0.434
1992 Prywes R, Zhu H. In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators. Nucleic Acids Research. 20: 513-20. PMID 1531519 DOI: 10.1093/Nar/20.3.513  0.435
1992 Han TH, Lamph WW, Prywes R. Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-jun promoter. Molecular and Cellular Biology. 12: 4472-7. PMID 1406636 DOI: 10.1128/Mcb.12.10.4472  0.386
1991 Manak JR, Prywes R. Mutation of serum response factor phosphorylation sites and the mechanism by which its DNA-binding activity is increased by casein kinase II. Molecular and Cellular Biology. 11: 3652-9. PMID 2046671 DOI: 10.1128/Mcb.11.7.3652  0.371
1991 Zhu H, Roy AL, Roeder RG, Prywes R. Serum response factor affects preinitiation complex formation by TFIID in vitro. The New Biologist. 3: 455-64. PMID 1909174  0.315
1991 Dash PK, Karl KA, Colicos MA, Prywes R, Kandel ER. cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proceedings of the National Academy of Sciences of the United States of America. 88: 5061-5. PMID 1647024 DOI: 10.1073/Pnas.88.11.5061  0.42
1989 Levi BZ, Kasik JW, Burke PA, Prywes R, Roeder RG, Appella E, Ozato K. Neonatal induction of a nuclear protein that binds to the c-fos enhancer. Proceedings of the National Academy of Sciences of the United States of America. 86: 2262-6. PMID 2928331 DOI: 10.1073/Pnas.86.7.2262  0.329
1989 Fisch TM, Prywes R, Roeder RG. An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate. Molecular and Cellular Biology. 9: 1327-31. PMID 2498646 DOI: 10.1128/mcb.9.3.1327-1331.1989  0.334
1988 Livneh E, Dull TJ, Berent E, Prywes R, Ullrich A, Schlessinger J. Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor. Molecular and Cellular Biology. 8: 2302-8. PMID 3136317 DOI: 10.1128/Mcb.8.6.2302  0.475
1986 Prywes R, Livneh E, Ullrich A, Schlessinger J. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. The Embo Journal. 5: 2179-90. PMID 3490969 DOI: 10.1002/J.1460-2075.1986.Tb04482.X  0.457
1986 Prywes R, Roeder RG. Inducible binding of a factor to the c-fos enhancer. Cell. 47: 777-84. PMID 3096578 DOI: 10.1016/0092-8674(86)90520-9  0.305
1986 Livneh E, Prywes R, Kashles O, Reiss N, Sasson I, Mory Y, Ullrich A, Schlessinger J. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. The Journal of Biological Chemistry. 261: 12490-7. PMID 3017977  0.437
1986 Livneh E, Benveniste M, Prywes R, Felder S, Kam Z, Schlessinger J. Large deletions in the cytoplasmic kinase domain of the epidermal growth factor receptor do not affect its laternal mobility. The Journal of Cell Biology. 103: 327-31. PMID 3015981 DOI: 10.1083/Jcb.103.2.327  0.432
1985 Prywes R, Hoag J, Rosenberg N, Baltimore D. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus. Journal of Virology. 54: 123-32. PMID 2983109 DOI: 10.1128/Jvi.54.1.123-132.1985  0.445
1985 Prywes R, Foulkes JG, Baltimore D. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. Journal of Virology. 54: 114-22. PMID 2983108 DOI: 10.1128/Jvi.54.1.114-122.1985  0.432
1983 Wang JY, Prywes R, Baltimore D. Structure and function of the Abelson murine leukemia virus transforming gene. Progress in Clinical and Biological Research. 119: 57-63. PMID 6306691  0.64
1983 Prywes R, Foulkes JG, Rosenberg N, Baltimore D. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell. 34: 569-79. PMID 6193890 DOI: 10.1016/0092-8674(83)90389-6  0.402
Low-probability matches (unlikely to be authored by this person)
2002 Andreucci JJ, Grant D, Cox DM, Tomc LK, Prywes R, Goldhamer DJ, Rodrigues N, Bédard PA, McDermott JC. Composition and function of AP-1 transcription complexes during muscle cell differentiation. The Journal of Biological Chemistry. 277: 16426-32. PMID 11877423 DOI: 10.1074/Jbc.M110891200  0.297
1987 Fisch TM, Prywes R, Roeder RG. c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Molecular and Cellular Biology. 7: 3490-502. PMID 3119989 DOI: 10.1128/mcb.7.10.3490-3502.1987  0.292
1988 Prywes R, Dutta A, Cromlish JA, Roeder RG. Phosphorylation of serum response factor, a factor that binds to the serum response element of the c-FOS enhancer. Proceedings of the National Academy of Sciences of the United States of America. 85: 7206-10. PMID 2845402 DOI: 10.1073/Pnas.85.19.7206  0.286
2001 Steiner H, Winkler E, Shearman MS, Prywes R, Haass C. Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins. Neurobiology of Disease. 8: 717-22. PMID 11493036 DOI: 10.1006/Nbdi.2001.0405  0.286
1989 Boxer LM, Prywes R, Roeder RG, Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Molecular and Cellular Biology. 9: 515-22. PMID 2710114 DOI: 10.1128/mcb.9.2.515-522.1989  0.282
1994 Zhu H, Joliot V, Prywes R. Role of transcription factor TFIIF in serum response factor-activated transcription. The Journal of Biological Chemistry. 269: 3489-97. PMID 8106390  0.267
1997 Prywes R. Analysis of transcription by RNA polymerase II in vitro. Methods (San Diego, Calif.). 12: 189-91. PMID 9252270 DOI: 10.1006/Meth.1997.0470  0.26
1989 Fisch TM, Prywes R, Simon MC, Roeder RG. Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes & Development. 3: 198-211. PMID 2541049 DOI: 10.1101/gad.3.2.198  0.253
2000 Blaeser F, Ho N, Prywes R, Chatila TA. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. The Journal of Biological Chemistry. 275: 197-209. PMID 10617605  0.252
1988 Prywes R, Fisch TM, Roeder RG. Transcriptional regulation of c-fos. Cold Spring Harbor Symposia On Quantitative Biology. 53: 739-48. PMID 3151186  0.246
1990 Manak JR, de Bisschop N, Kris RM, Prywes R. Casein kinase II enhances the DNA binding activity of serum response factor. Genes & Development. 4: 955-67. PMID 2200737  0.209
1998 Wei L, Zhou W, Croissant JD, Johansen FE, Prywes R, Balasubramanyam A, Schwartz RJ. RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. The Journal of Biological Chemistry. 273: 30287-94. PMID 9804789  0.203
1987 Prywes R, Roeder RG. Purification of the c-fos enhancer-binding protein. Molecular and Cellular Biology. 7: 3482-9. PMID 3316979 DOI: 10.1128/mcb.7.10.3482-3489.1987  0.199
1994 Kim JH, Johansen FE, Robertson N, Catino JJ, Prywes R, Kumar CC. Suppression of Ras transformation by serum response factor. The Journal of Biological Chemistry. 269: 13740-3. PMID 8188648  0.113
1969 Legg S, Davies AM, Prywes R, Sterk VV, Weiskopf P. The jerusalem perinatal study. 2. Infant deaths 1964-66: a cohort study of socioethnic factors in deaths from congenital malformations and from environmental and other causes. Israel Journal of Medical Sciences. 5: 1107-16. PMID 5365595  0.055
1976 Prywes R, Harlap S, Davies AM. [Neonatal death after induced abortion]. Harefuah. 90: 453-6. PMID 986985  0.046
1972 Harlap S, Davies AM, Haber M, Prywes R, Rossman H, Samueloff N. Patterns of medication in early pregnancy: a preliminary report from the Jerusalem perinatal study. Advances in Experimental Medicine and Biology. 27: 489-504. PMID 4680142 DOI: 10.1007/978-1-4684-3219-0_42  0.033
1976 Davies AM, Poznansky R, Weiskopf P, Prywes R, Sadovsky E, Czaczkes W. Toxemia of pregnancy in Jerusalem. II. The role of diet. Israel Journal of Medical Sciences. 12: 509-18. PMID 955866  0.02
1980 Naggan L, Bar-Shany S, Shmuelewitz O, Finzi M, Prywes R. Prevalence of hepatitis B markers (HBsAg and HBsAb) in women screened at time of delivery. Israel Journal of Medical Sciences. 16: 347-50. PMID 7399863  0.01
1977 Harlap S, Prywes R, Grover NB, Davies AM. Maternal, perinatal and infant health in Bedouin and Jews in southern Israel. Israel Journal of Medical Sciences. 13: 514-28. PMID 873768  0.01
1977 Czaczkes JW, Prywes R, Keynan A, Sadovsky E. Prevalence of elevated blood pressure in a village community with a high incidence of toxemia of pregnancy. Israel Journal of Medical Sciences. 13: 1147-50. PMID 598993  0.01
1977 Harlap S, Davies AM, Grover NB, Prywes R. The Jerusalem perinatal study: the first decade 1964--73. Israel Journal of Medical Sciences. 13: 1073-91. PMID 591301  0.01
1976 Harlap S, Prywes R, Grover NB, Davies AM. Fertility and perinatal and infant mortality in the Jewish population of Beersheba and the Negev, 1972. Israel Journal of Medical Sciences. 12: 1418-31. PMID 1017940  0.01
1975 Harlap S, Prywes R, Davies AM. Letter: Birth defects and oestrogens and progesterones in pregnancy. Lancet (London, England). 1: 682-3. PMID 47104  0.01
1971 Sterk VV, Prywes R, Davies AM, Ever-Hadani P, Lilos P. Vomiting during pregnancy in Jerusalem women. Israel Journal of Medical Sciences. 7: 1248-55. PMID 5159606  0.01
1971 Harlap S, Kaufman R, Prywes R, Davies AM, Sterk VV, Weiskopf P. Patterns of obstetric intervention in a total population. A report from the Jerusalem perinatal study. Israel Journal of Medical Sciences. 7: 1115-27. PMID 5143178  0.01
1971 Harlap S, Davies AM, Haber M, Rossman H, Prywes R, Samueloff N. Congenital malformations in the Jerusalem perinatal study. An overview with special reference to maternal origin. Israel Journal of Medical Sciences. 7: 1520-8. PMID 4259389  0.01
1970 Davies AM, Czaczkes JW, Sadovsky E, Prywes R, Weiskopf P, Sterk VV. Toxemia of pregnancy in Jerusalem. I. Epidemiological studies of a total community. Israel Journal of Medical Sciences. 6: 253-66. PMID 5506239  0.01
1970 Legg S, Davies AM, Prywes R, Sterk VV, Weiskopf P. Patterns of low birth weight in West Jerusalem with special reference to maternal origin. British Journal of Preventive & Social Medicine. 24: 89-96. PMID 5431073  0.01
1969 Davies AM, Prywes R, Tzur B, Weiskopf P, Sterk VV. The Jerusalem perinatal study. 1. Design and organization of a continuing, community-based, record-linked survey. Israel Journal of Medical Sciences. 5: 1095-106. PMID 5365594  0.01
Hide low-probability matches.